Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.

@article{Grandi2015PelvicPA,
  title={Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.},
  author={Giovanni Grandi and Anjeza Xholli and Antonella Napolitano and Federica Palma and Angelo Cagnacci},
  journal={Reproductive sciences},
  year={2015},
  volume={22 5},
  pages={626-32}
}
OBJECTIVE The progestin dienogest (DNG) given alone effectively reduces pelvic pain of women with endometriosis. It is not clear whether the same occurs when DNG is associated with estradiol (E2). DESIGN Patient preference prospective observational study. SETTING Outpatient centre of university hospital. PATIENTS 40 patients with endometriosis and menstrual pain. INTERVENTIONS 24-week treatment with a quadriphasic association of E2 valerate (E2V) and DNG or a nonsteroidal anti… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

An update on the pharmacological management of endometriosis

  • I Streuli, D de Ziegler, P Santulli
  • Expert Opin Pharmacother
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…